Edit |   |
---|---|
Product Name | XL184 |
Description | A VEGFR2 inhibitor (IC50 = 0.035 nM); selective for VEGFR2 over Ron, EGFR, IGF-1R, and EphA4/B4; inhibits c-Met, RET, c-Kit, Axl, FLT3, and Tie2 (IC50s = 1.3, 5.2, 4.6, 7, 11.3, and 14.3 nM, respectively); inhibits VEGF-induced tubule formation in HMVECs at 4.6 nM; reduces HGF-induced migration and invasion of B16/F10 cells at 123 nM; induces tumor regression in an MDA-MB-231 breast cancer mouse xenograft model at 60 mg/kg; does not increase the number of pulmonary tumor foci in an MDA-MB-231 mouse metastasis model; protects primary placental fibroblasts from Zika virus infection |
Size | 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | BMS-907351|Cabozantinib |
Gene, Accession, CAS # | CAS: 849217-68-1 |
Catalog # | 18464-50 |
Price | $533.00 |
Order / More Info | XL184 from CAYMAN CHEMICAL COMPANY |
Product Specific References | n/a |